Skip to content
Cash Flow Statement · TASI 8150

Allied Cooperative Insurance Group
Cash and cash equivalents at period end · Insurance operations history.

Cash and cash equivalents at the end of each reporting period. Figures apply to insurance operations. Explore 18 reported observations from 2018 to 2022, with every value linked to its official evidence.

Coverage2018–202218 source-linked periods
Annual history3annual reporting periods
Interim history15quarterly or year-to-date periods
StatementCash Flow Statementas reported by the issuer
Annual series

Cash and cash equivalents at period end · Insurance operations

The series uses the same reporting duration and currency. The filing values appear below.

2020IFRS 4Cash and cash equivalents at period end · Insurance operations72.73M SAR
Cash and cash equivalents at period end · Insurance operations020M40M60M80M100M201820192020
Hover or tap to exploreSAR
First-quarter series

Cash and cash equivalents at period end · Insurance operations

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Cash and cash equivalents at period end · Insurance operations101.76M SAR
Cash and cash equivalents at period end · Insurance operations050M100M150M200M20182019202020212022
Hover or tap to exploreSAR
Half-year series

Cash and cash equivalents at period end · Insurance operations

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Cash and cash equivalents at period end · Insurance operations135.87M SAR
Cash and cash equivalents at period end · Insurance operations0100M200M300M20182019202020212022
Hover or tap to exploreSAR
Nine-month series

Cash and cash equivalents at period end · Insurance operations

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Cash and cash equivalents at period end · Insurance operations341.2M SAR
Cash and cash equivalents at period end · Insurance operations0100M200M300M400M20182019202020212022
Hover or tap to exploreSAR
Official evidence ledger

Every value, period and source.

Normalized values support comparison. The reported value and unit preserve the original filing presentation.

PeriodReported valueComparable valueReported lineEvidence
9M / Q3 20222022-09-30341,2042022-01-01 to 2022-09-30341.2M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
H1 / Q2 20222022-06-30135,8672022-01-01 to 2022-06-30135.87M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
Q1 20222022-03-31101,7602022-01-01 to 2022-03-31101.76M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
9M / Q3 20212021-09-30181,5982021-01-01 to 2021-09-30181.6M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
H1 / Q2 20212021-06-30188,3392021-01-01 to 2021-06-30188.34M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
Q1 20212021-03-3166,3442021-01-01 to 2021-03-3166.34M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
FY 20202020-12-3172,7252020-01-01 to 2020-12-3172.73M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
9M / Q3 20202020-09-30207,4682020-01-01 to 2020-09-30207.47M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
H1 / Q2 20202020-06-30243,8122020-01-01 to 2020-06-30243.81M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
Q1 20202020-03-31188,0692020-01-01 to 2020-03-31188.07M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
FY 20192019-12-3165,3202019-01-01 to 2019-12-3165.32M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
9M / Q3 20192019-09-3094,4052019-01-01 to 2019-09-3094.41M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
H1 / Q2 20192019-06-3075,7502019-01-01 to 2019-06-3075.75M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
Q1 20192019-03-3192,1302019-01-01 to 2019-03-3192.13M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
FY 20182018-12-3183,4092018-01-01 to 2018-12-3183.41M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
9M / Q3 20182018-09-3097,9912018-01-01 to 2018-09-3097.99M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
H1 / Q2 20182018-06-3066,4212018-01-01 to 2018-06-3066.42M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
Q1 20182018-03-3140,6442018-01-01 to 2018-03-3140.64M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
How to read this series

Reported first. Comparable second.

We show the original label and figure alongside its normalized value. Annual, first-quarter, half-year and nine-month series are separate. Per-share figures keep the issuer’s reported share basis.

سجل مالي موثق بالمصدر

أسيج — Cash and cash equivalents at period end · Insurance operations

تُعرض القيم كما وردت في القوائم المالية الرسمية، مع فصل الفترات السنوية والمرحلية وربط كل قيمة بصفحة المصدر الرسمي. تُعرض ربحية السهم وفق أساس الأسهم الوارد في كل تقرير.